33 Pathogenesis of sepsis References 1. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. The Lancet Infectious diseases. 2008;8(1):32-43. 2. van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nature reviews Immunology. 2017;17(7):407-20. 3. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):801-10. 4. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. Jama. 2009;302(21):2323-9. 5. Opal SM, Garber GE, LaRosa SP, Maki DG, Freebairn RC, Kinasewitz GT, et al. Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2003;37(1):50-8. 6. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al. Drotrecogin alfa (activated) in adults with septic shock. The New England journal of medicine. 2012;366(22):2055-64. 7. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature immunology. 2010;11(5):373-84. 8. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):80520. 9. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, et al. Alarmins: awaiting a clinical response. The Journal of clinical investigation. 2012;122(8):2711-9. 10. Satoh T, Akira S. Toll-Like Receptor Signaling and Its Inducible Proteins. Microbiol Spectr. 2016;4(6). 11. Inohara, Chamaillard, McDonald C, Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annual review of biochemistry. 2005;74:355-83. 12. Franchi L, Munoz-Planillo R, Nunez G. Sensing and reacting to microbes through the inflammasomes. Nature immunology. 2012;13(4):325-32. 13. Takeuchi O, Akira S. Innate immunity to virus infection. Immunological reviews. 2009;227(1):75-86. 14. Yoneyama M, Fujita T. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity. 2008;29(2):178-81. 15. Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nature immunology. 2006;7(12):1266-73. 16. Liew FY, Xu D, Brint EK, O’Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nature reviews Immunology. 2005;5(6):446-58. 17. Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement System Part II: Role in Immunity. Frontiers in immunology. 2015;6:257. 18. Sarma JV, Ward PA. The complement system. Cell and tissue research. 2011;343(1):227-35. 19. Ward PA. The harmful role of c5a on innate immunity in sepsis. Journal of innate immunity. 2010;2(5):439-45. 20. Guo RF, Ward PA. Role of C5a in inflammatory responses. Annual review of immunology. 2005;23:821-52. 21. Levi M, van der Poll T. Coagulation and sepsis. Thrombosis research. 2017;149:38-44. 22. Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nature reviews Disease primers. 2016;2:16037. 23. Levi M, van der Poll T. Inflammation and coagulation. Critical care medicine. 2010;38(2 Suppl):S26-34. 2
RkJQdWJsaXNoZXIy MTk4NDMw